Community-reported Ontak side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Ontak Side Effect
Have You dealt with a Ontak side effect? Share your experience
Review Ontak Safety Reports submitted to FDA
Total Ontak reports: 28.Ontak FDA safety alerts: 2005 2006 2007 .
Reported deaths: 20 Reported hospitalizations: 19.
Take Ontak Side Effects Survey, Discuss Ontak with others
FDA Reported Ontak Side Effects: rhabdomyolysis, capillary leak syndrome, hypotension, haemolysis, electromechanical dissociation, bradycardia, febrile neutropenia, rash maculo-papular, pyrexia, blood alkaline phosphatase increased, blood albumin decreased.
Ontak Usage.
If you have questions about Ontak, you can ask a Health Expert or Ask Patient Community about Ontak.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Ontak Side Effects Report #5663754-2
Physician from UNITED STATES reported ONTAK problem on Feb 25, 2008. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fatigue, leukopenia, neutropenia, thrombocytopenia. ONTAK dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, PLAVIX, TOPROL, ASPIRIN. Patient recovered.
Ontak Side Effects Report #5663755-4
ONTAK problem was reported by a Physician from UNITED STATES on Feb 28, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: asthenia, bradycardia, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation, malaise, nausea, pain. ONTAK dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.
Ontak Side Effects Report #5663756-6
Physician from UNITED STATES reported ONTAK problem on Feb 25, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, cardiac arrest, dizziness, haematocrit increased, insomnia. ONTAK dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBIENE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 01/19/2008.
Ontak Side Effects Report #5675840-1
ONTAK problem was reported by a Health Professional from UNITED STATES on Mar 03, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, back pain, blood glucose increased, cardio-respiratory arrest, cardiomegaly, musculoskeletal pain, nausea, overweight. ONTAK dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS; INTERMITTENT SINCE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.
Ontak Side Effects Report #5615032-5
Health Professional from UNITED STATES reported ONTAK problem on Jan 24, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardiac arrest, dizziness, insomnia, pain, vomiting. ONTAK dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBIENE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 01/19/2008.
Ontak Side Effects Report #5615033-7
ONTAK problem was reported by a Physician from UNITED STATES on Jan 23, 2008. Female patient, 53 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, chest pain, hyperthyroidism, nausea, palpitations, vomiting. ONTAK dosage: unknown. Patient was hospitalized. Patient recovered.
Ontak Side Effects Report #5615035-0
Physician from UNITED STATES reported ONTAK problem on Jan 23, 2008. Female patient, 53 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, dizziness, goitre, hyperthyroidism, tachycardia, tremor. ONTAK dosage: unknown. Patient was hospitalized. Patient recovered.
Ontak Side Effects Report #5615037-4
ONTAK problem was reported by a Physician from UNITED STATES on Jan 18, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dizziness, insomnia, pain, vomiting. ONTAK dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBIENE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 01/19/2008.
Ontak Side Effects Report #5643730-6
Health Professional from UNITED STATES reported ONTAK problem on Feb 11, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardiac arrest, cardiomegaly, dizziness, hepatic congestion, insomnia, oedema. ONTAK dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBIENE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 01/19/2008.
Ontak Side Effects Report #5586199-2
ONTAK problem was reported by a Health Professional from UNITED STATES on Dec 24, 2007. Female patient, 45 years of age, weighting 280.0 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: back pain, bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, pain in extremity, pain in jaw, sinus tachycardia. ONTAK dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 12/19/2007.
Ontak Side Effects Report #5599265-2
Health Professional from UNITED STATES reported ONTAK problem on Jan 03, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, sinus tachycardia, unresponsive to stimuli. ONTAK dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.
Ontak Side Effects Report #5525331-3
ONTAK problem was reported by a Health Professional from UNITED STATES on Nov 08, 2007. Male patient, 48 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: polymyositis. ONTAK dosage: unknown. During the same period patient was treated with NARCOTICS. Patient recovered.
Ontak Side Effects Report #5530610-X
Pharmacist from UNITED STATES reported ONTAK problem on Nov 28, 2007. Male patient, 54 years of age, weighting 213.8 lb, was diagnosed with t-cell lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, dizziness, metabolic acidosis, multi-organ failure, respiratory failure, shock, syncope, systemic inflammatory response syndrome. ONTAK dosage: unknown. Patient died on 04/23/2007.
Ontak Side Effects Report #5448922-7
ONTAK problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 66 years of age, weighting 134.5 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood lactic acid increased, bradycardia, capillary leak syndrome, cardiac arrest, electromechanical dissociation, haemolysis, hypotension, lymphocyte percentage decreased. ONTAK dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBIVIN, CYTOXAN, PREDNISONE, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZDE. Patient died on 08/06/2007.
Ontak Side Effects Report #5455508-7
Physician from UNITED STATES reported ONTAK problem on Aug 30, 2007. Male patient, 70 years of age, was diagnosed with lymphadenopathy, mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood alkaline phosphatase increased, pyrexia, rash maculo-papular. ONTAK dosage: unknown. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.
Ontak Side Effects Report #5457776-4
ONTAK problem was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with panniculitis and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. ONTAK dosage: unknown. During the same period patient was treated with PREDNISONE, AZATHIOPRINE, SYNTHROID, ALLOPURINOL, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Ontak Side Effects Report #5417991-2
Physician from UNITED STATES reported ONTAK problem on Aug 06, 2007. Female patient, 66 years of age, weighting 134.5 lb, was diagnosed with hypertension and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ONTAK dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, CYTOXAN, PREDNISONE, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient died on 08/06/2007.
Ontak Side Effects Report #5418039-6
ONTAK problem was reported by a Physician from UNITED STATES on Aug 06, 2007. Female patient, 66 years of age, weighting 134.5 lb, was diagnosed with hypertension and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ONTAK dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, CYTOXAN, PREDNISONE, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient died on 08/06/2007.
Ontak Side Effects Report #5427734-4
Pharmacist from UNITED STATES reported ONTAK problem on Aug 14, 2007. Female patient, 66 years of age, weighting 134.5 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: bradycardia, capillary leak syndrome, electromechanical dissociation, haemolysis, hypotension, myocardial infarction, rhabdomyolysis, tumour lysis syndrome, ventricular fibrillation. ONTAK dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, CYTOXAN, PREDNISONE, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient died on 08/06/2007.
Ontak Side Effects Report #5694173-0
ONTAK problem was reported by a Physician from UNITED STATES on Mar 20, 2008. Male patient, 53 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: acidosis, blood albumin decreased, capillary leak syndrome, cold sweat, cyanosis, dizziness, hypotension, hypoxia. ONTAK dosage: unknown. During the same period patient was treated with DEXAMETHASONE, SALINE SOLUTION. Patient was hospitalized. Patient died.
Ontak Side Effects Report #5694174-2
Physician from UNITED STATES reported ONTAK problem on Mar 20, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with lymphoma and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood amylase increased, blood bicarbonate decreased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, capillary leak syndrome, cardiac arrest, dizziness. ONTAK dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBIENE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 01/19/2008.
Ontak Side Effects Report #5710514-X
ONTAK problem was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, back pain, blood creatine phosphokinase increased, blood glucose increased, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation. ONTAK dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.
Ontak Side Effects Report #5717053-0
Physician from UNITED STATES reported ONTAK problem on Apr 09, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, arthralgia, asthenia, back pain, bradycardia, cardiac arrest, cardio-respiratory arrest, cardiomegaly, dyspnoea. ONTAK dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.
Ontak Side Effects Report #5718724-2
ONTAK problem was reported by a Physician from AUSTRALIA on Apr 09, 2008. Male patient, 42 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: disease progression. ONTAK dosage: 18 MG, INTRAVENOUS INFUSION. Patient died.
Ontak Side Effects Report #5723490-0
Physician from UNITED STATES reported ONTAK problem on June 11, 2007. Male patient was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome. ONTAK dosage: unknown. Patient died.
Ontak Side Effects Report #5723492-4
ONTAK problem was reported by a Physician from UNITED STATES on Aug 02, 2007. Male patient, 55 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: angiopathy, chills, dyspnoea, pyrexia. ONTAK dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, PREDNISONE, CYTOXAN, NEULASTA. Patient was hospitalized. Patient recovered.
Ontak Side Effects Report #5723498-5
Physician from UNITED STATES reported ONTAK problem on Jan 23, 2008. Female patient, 53 years of age, was diagnosed with mycosis fungoides and was treated with ONTAK. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, hyperthyroidism. ONTAK dosage: unknown. Patient was hospitalized. Patient recovered.
Ontak Side Effects Report #5320951-3
ONTAK problem was reported by a Physician from UNITED STATES on Apr 23, 2007. Male patient, 53 years of age, was diagnosed with lymphoma and was treated with ONTAK. ONTAK dosage: unknown. Patient died on 04/23/2007.